Citation only
via OpenAlex
Effects of lifespan-extending interventions on cognitive healthspan
Luka Čulig, Burcin Duan Sahbaz, Vilhelm A. Bohr
Expert Reviews in Molecular Medicine · 2022 · ▲ 15 citations
Epigenetic alterations
Cellular senescence
Caloric restriction
Senolytics
Rapamycin / mTOR inhibition
Metformin
Spermidine
Exercise
Partial reprogramming (OSK)
Randomized controlled trial
Review
Abstract
Ageing is known to be the primary risk factor for most neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and Huntington's disease. They are currently incurable and worsen over time, which has broad implications in the context of lifespan and healthspan(definition) extension. Adding years to life and even to physical health is suboptimal or even insufficient, if cognitive ageing is not adequately improved. In this review, we will examine how interventions that have the potential to extend lifespan in animals affect the brain, and if they would be able to thwart or delay the development of cognitive dysfunction and/or neurodegeneration. These interventions range from lifestyle (caloric restriction(definition), physical exercise and environmental enrichment) through pharmacological (nicotinamide adenine dinucleotide precursors, resveratrol, mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), metformin, spermidine and senolytics(definition)) to epigenetic reprogramming. We argue that while many of these interventions have clear potential to improve cognitive health and resilience, large-scale and long-term randomised controlled trials are needed, along with studies utilising washout periods to determine the effects of supplementation cessation, particularly in aged individuals.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1017/erm.2022.36
- Canonical
- link ↗
- Fetched
- 2026-06-14 MST
Cite this
APA
Čulig, L., Sahbaz, B.D., & Bohr, V.A. (2022). Effects of lifespan-extending interventions on cognitive healthspan. <em>Expert Reviews in Molecular Medicine</em>. https://doi.org/10.1017/erm.2022.36
Vancouver
Čulig L, Sahbaz BD, Bohr VA. Effects of lifespan-extending interventions on cognitive healthspan. Expert Reviews in Molecular Medicine. 2022. doi:10.1017/erm.2022.36.
BibTeX
@article{luka2022Effect,
title = {Effects of lifespan-extending interventions on cognitive healthspan},
author = {Luka Čulig and Burcin Duan Sahbaz and Vilhelm A. Bohr},
journal = {Expert Reviews in Molecular Medicine},
year = {2022},
doi = {10.1017/erm.2022.36},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pennington Biomedical Research Center 2021
Open access · US-GOV
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-Mild Cognitive Impairment Cohort
European Journal of Preventive Cardiology 2025
Open access · CC-BY
Physical activity and mortality: towards healthspan-oriented metrics and outcomes. A Scientific Statement from the European Association of Preventive Cardiology (EAPC) of the ESC
Neural Regeneration Research 2019
Open access · CC-BY
Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
Journal of genetics and genomics/Journal of Genetics and Genomics 2014
Open access · CC-BY
Lifespan Modulation in Mice and the Confounding Effects of Genetic Background
Fundacion para la Investigacion y Formacion en Ciencias de la Salud 2010
Open access · US-GOV
Detection of Mild Cognitive Impairment in People Older Than 65 Years of Age and Its Relationship to Cardiovascular Risk Factors (DECRIVAM)
Molecular Neurobiology 2016
Citation only